Barclays’s Cellectar Biosciences CLRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,017
Closed -$258K 4370
2024
Q3
$258K Sell
4,017
-1,723
-30% -$111K ﹤0.01% 3352
2024
Q2
$430K Sell
5,740
-5,533
-49% -$414K ﹤0.01% 2618
2024
Q1
$1.35M Buy
+11,273
New +$1.35M ﹤0.01% 2203
2021
Q2
Sell
-1
Closed -$1K 4087
2021
Q1
$1K Buy
+1
New +$1K ﹤0.01% 3850